Astellas Pharma Inc (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 2,786,060 | 0 | 0 | 0 | 3,040,400 |
| Cost of Goods | 874,910 | N/A | N/A | N/A | 917,930 |
| Gross Profit | 1,911,140 | N/A | N/A | N/A | 2,122,460 |
| Operating Expenses | 1,522,770 | 0 | 0 | 0 | 1,462,240 |
| Operating Income | 389,290 | N/A | N/A | N/A | 661,160 |
| Other Income | -81,300 | 0 | 0 | 0 | -64,980 |
| Pre-tax Income | 307,990 | 0 | 0 | 0 | 596,180 |
| Income Tax | 84,570 | N/A | N/A | N/A | 152,570 |
| Net Income Continuous | 223,420 | N/A | N/A | N/A | 443,610 |
| Net Income | $223,420 | $N/A | $N/A | $N/A | $443,610 |
| EBITDA(a) | $389,290 | $N/A | $N/A | $N/A | $661,160 |